Audrey L. French

Audrey L. French

Auto-generated profile, based on publicly available information

Audrey L. French

Department of Medicine, University of Illinois Chicago, Chicago IL, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2021 in JMIR Formative Research
Verified
Journal Article
Open access
NGNeil Gleason
Neil Gleason
PSPedro A Serrano
Pedro A Serrano
AMAlejandro Muñoz
Alejandro Muñoz
AFAudrey French
Audrey French
SHSybil Hosek
Sybil Hosek
Background: HIV infection rates among sexual minority men and transgender individuals, particularly adolescents and young adults, remain elevated in the United States despite continued improvement in the HIV public health response. However, there remains a knowledge gap in understanding the barriers faced by this community in receiving HIV care and prevention resources. To address this, the Keeping it LITE study was conducted to assess HIV risk factors and barriers to preventive treatment in a large national cohort of young sexual minority men and transgender individuals at high risk of HIV infection. Objective: This study aims to evaluate the feasibility of enrolling a large remote cohort, challenges encountered in recruitment, and adjustments made to address these challenges. Methods: A large national cohort (n=3444) of young sexual minority men and transgender individuals were recruited. Participants were recruited via advertisements on social media; social apps for lesbian, gay, bisexual, transgender, and queer individuals; print advertising; and word-of-mouth. Before enrolling, participants verified their HIV status using an at-home HIV test or by providing their own testing documentation. Descriptive statistics were generated, and a series of logistic regressions were conducted to evaluate demographic differences between recruitment methods, HIV testing methods, and enrollment status. Results: The Keeping it LITE study was particularly successful in recruiting participants via social media, with over half of the participants recruited from advertisements on social media platforms such as Facebook, Instagram, and Snapchat. Participants were also recruited via word-of-mouth; lesbian, gay, bisexual, transgender, and queer apps (ie, Grindr, Scruff); and print advertisements, and participants recruited from these sources tended to be older and have a higher risk profile. The study was also successful in recruiting a large sample of transgender youth, particularly transgender men and nonbinary individuals. At-home HIV testing was acceptable and more heavily used by younger participants, although several barriers were encountered and overcome in the implementation of this testing. The study had more limited success in recruiting participants aged 13-17 years because of lower enrollment rates and barriers to advertising on social media platforms. The implications of these findings for the future development of HIV research and intervention protocols among sexual minorities and trans youth are discussed. Conclusions: The methods used in the Keeping it LITE study, particularly recruitment via social media, were found to be feasible and acceptable to participants.

26 April 2018 in AIDS Care
Verified
Journal Article
Open access
EAEaden Andu
Eaden Andu
BWBrad H. Wagenaar
Brad H. Wagenaar
CKChris G. Kemp
Chris G. Kemp
PNPaul E. Nevin
Paul E. Nevin
JSJan Simoni
Jan Simoni
DRDeepa Rao
Deepa Rao
We sought to examine risk and protective factors for Posttraumatic Stress Disorder (PTSD) among African American women living with HIV. This is a cross-sectional analysis of baseline data from a randomized trial of an HIV stigma reduction intervention. We examined data from two-hundred and thirty-nine African American women living with HIV. We examined whether age, marital status, level of education, internalized HIV-related stigma, and social support as potential protective and risk factors for PTSD symptoms using logistic regression. We analyzed bi-variate associations between each variable and PTSD symptoms, and constructed a multivariate logistic regression model adjusting for all variables. We found 67% reported clinically significant PTSD symptoms at baseline. Our results suggest that age, education, and internalized stigma were found to be associated with PTSD symptoms (p < 0.001), with older age and more education as protective factors and stigma as a risk factor for PTSD. Therefore, understanding this relationship may help improve assessment and treatment through evidence- based and trauma-informed strategies.

16 February 2026 in Brain, Behavior, & Immunity - Health
Verified
Journal Article
Open access
VGVilma Gabbay
Vilma Gabbay
CHCaitlin Hills
Caitlin Hills
FCFrancisco Cardozo
Francisco Cardozo
ACAaron B. Chance
Aaron B. Chance
ASAnjali Sharma
Anjali Sharma
AFAudrey L. French
Audrey L. French
The kynurenine pathway (KP) has been implicated in cytokine-induced depression and anhedonia, a core depression symptom. We examined KP metabolites in relation to depression and anhedonia symptom severity in women with and without HIV (WWH and WWoH). Participants included 239 women (55% WWH, mean age 52 years). Depressive symptoms were measured using the Center for Epidemiologic Studies Depression (CES-D) scale and high depressive symptoms were defined as a score ≥16; anhedonia severity was quantified on two CES-D items. KP metabolites, including quinolinic acid (QA, NMDA receptor agonist) and kynurenic acid (KA, NMDA receptor antagonist), were measured using liquid chromatography-tandem mass spectrometry. Adjusted multivariable linear regression was used to compare metabolites among groups and to assess relationships of KP metabolites with anhedonia and depressive symptoms. A greater proportion of WWH had high depression severity (CES-D ≥16) than WWoH (23% vs. 12%; p = .03). WWH with CES-D≥16 had greater QA compared to WWH with CES-D<16 (diff = 0.52 SD; p = .02). Using a dimensional quantitative approach, QA levels were positively associated with depressive (β = 0.25; p = .01) and anhedonia symptom severity (β = 0.24; p = .01) among WWH, but not in WWoH. Conversely, KA was inversely associated with anhedonia symptom severity in WWH (β = −0.20; p =.03) and WWoH (β = −0.23; p =.02). This study extends understanding of the role of the KP in depression and anhedonia to WWH and suggests neuroactive metabolites as a possible underlying mechanism. The KP may affect reward neuro-circuitry through increased QA neurotoxicity and decreased KA neuroprotection.

29 June 2026 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
CYChin-An Yang
Chin-An Yang
YGYoung-Mi Go
Young-Mi Go
DJDean P. Jones
Dean P. Jones
BBBrahmchetna Bedi
Brahmchetna Bedi
QYQian Yang
Qian Yang
CLCecile D Lahiri
Cecile D Lahiri
Integrase strand-transfer inhibitors (INSTIs) are associated with weight gain in people with HIV (PWH), particularly in women with HIV (WWH), but underlying mechanisms remain unclear. We used longitudinal untargeted metabolomics to identify metabolic signatures of INSTI-related weight gain in WWH. We analyzed serum from 192 participants in the Women's Interagency HIV Study: 38 virologically suppressed WWH who initiated INSTIs (INSTI group), 88 virologically suppressed WWH who remained on their original antiretroviral therapy (non-INSTI group), and 66 women without HIV (WWoH). Samples were collected at baseline (6-12 months before INSTI initiation), 1-6 months post-initiation, and 1-2 years post-initiation, with matched visits for controls. High-resolution metabolomics was performed by liquid chromatography-mass spectrometry. Within each group, linear mixed-effects models adjusted for baseline age and BMI compared longitudinal metabolite changes between weight gainers and maintainers, and significant features were analyzed by Mummichog v2.0 pathway enrichment. Mean age was 45.7 ± 8.9 years and mean BMI 32.4 ± 8.3 kg/m2, with no differences across groups; within each group, gainers and maintainers were demographically comparable (p > 0.05). In the INSTI group, metabolites differentiating gainers from maintainers were enriched in 16 pathways across timepoints, predominantly lipid-related (56%), including the polyunsaturated fatty acid (PUFA) pathways linoleic acid and arachidonic acid metabolism. In the non-INSTI and WWoH groups, differentiating metabolites spanned a broader range of pathways, including amino acid metabolism. Weight gain among INSTI-treated WWH is characterized by a distinct, lipid- and PUFA-dominated metabolic profile, providing mechanistic insight that may inform therapeutic strategies.

15 September 2026 in Journal of the Association of Nurses in AIDS Care
Verified
Journal Article
Closed access
RRRyan D. Ross
Ryan D. Ross
EDElizabeth Daubert
Elizabeth Daubert
SCStacey M. Cahoon
Stacey M. Cahoon
RHRuby Hernandez
Ruby Hernandez
DJDarlene Johnson
Darlene Johnson
KWKathleen M. Weber
Kathleen M. Weber
Joint pain is among the most common and disabling forms of chronic pain in women. Whether joint pain is more prevalent among women with versus without HIV (WWH/WWoH) and contributes to greater impairment is unknown. The Pain, Enjoyment, and General Activity instrument assessed joint pain in midlife WWH versus WWoH to determine associations with frailty, loneliness, and depressive/anxiety symptoms. Moderate/severe pain was more commonly reported in WWH than WWoH (44.1 vs. 38.3%) but not significantly. Women with moderate/severe joint pain were more likely to be prefrail/frail (aOR 3.05; confidence interval [CI]: 1.65–5.63) and report greater depressive symptomology (aOR 2.42; CI: 1.31–4.47), anxiety (aOR 3.38; CI: 1.53–7.43), and loneliness (aOR 1.84; CI: 1.02–3.29). Joint pain is highly prevalent in mid-life WWH and WWoH and associated with frailty, depression, anxiety, and loneliness. Identifying and addressing joint pain and associated conditions may improve multiple health domains in midlife women with and without HIV.

2 June 2026 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
MGMaria F Sanes Guevara
Maria F Sanes Guevara
KHKen S Ho
Ken S Ho
ASAnandi Sheth
Anandi Sheth
AEAndrew Edmonds
Andrew Edmonds
AFAudrey L French
Audrey L French
CLCecile Lahiri
Cecile Lahiri
Background: This study aimed to examine the prevalence of hepatitis B virus (HBV) in people with HIV (PWH) undergoing contemporary antiretroviral therapy and people without HIV and to understand the risk factors in people with HIV/HBV coinfection. This retrospective cross-sectional study included 5238 participants with HIV or at risk for HIV acquisition across 13 US sites in the MACS/WIHS Combined Cohort Study (Multicenter AIDS Cohort Study / Women Interagency HIV Study) between January 2018 and December 2024. Methods: The primary outcome was the prevalence of HBV infection and HIV/HBV coinfection. We defined a positive HBsAg (surface antigen) as chronic HBV infection, a negative HBsAg and positive anti-HBV core antibody as recovered infection, and a negative HBsAg and negative anti-HBV core antibody as never infection. The prevalence of chronic and recovered HBV infection was described in different risk groups. Results: In this cohort, the overall prevalence of chronic HBV was 2.4%, and HIV/HBV coinfection was 3.0% among PWH. Current and prior HBV infection was more common in men, and the prevalence of prior HBV increased with age. As compared with the other 2 groups, PWH with chronic HBV infection had lower CD4+ T-cell counts (567 vs 651 and 689 cells/µL), CD4+ T-cell nadirs (210 vs 245 and 258 cells/µL), and HIV viral suppression rate (71.7% vs 82.3% and 83.7%). Among PWH who never had HBV infection, 40.6% lacked seroprotection against HBV. Conclusions: HBV is still prevalent in PWH. HBV coinfection was associated with lower CD4+ T-cell counts and viral suppression rate in PWH. The low seroprotection rate in those without HBV underscores the need for improved screening and immunization.